IDEAS home Printed from https://ideas.repec.org/h/pal/psifcp/978-3-030-90115-8_9.html
   My bibliography  Save this book chapter

How Much Does Matter ESG Ratings in Big Pharma Firms Performances?

In: Climate Change Adaptation, Governance and New Issues of Value

Author

Listed:
  • Sophia Veronica Barbieri
  • Laura Pellegrini

    (University of Bari “Aldo Moro”)

Abstract

Given the peculiarities of the pharmaceutical sector and its wide exposure to ESG factors, this chapter aims to verify the possible presence and the strength of a relationship between firms ESG scores and their economic-financial performance. We consider a benchmark sample of 103 pharmaceutical companies listed around the world, exhibiting ESG scores from 2004 to 2018. Firstly, results showed that the governance score has a negative impact on ROA and a positive impact on Tobin's Q. Secondly, considering the firm size, all the ESG scores on which research hypotheses were tested gain statistical significance. In particular, for smaller pharmaceutical companies, both the governance and controversies score have a negative impact on ROA. While, as the firm size grows, the controversies score has a positive impact on both ROA and Tobin's Q. Finally, there is an inverted U-shaped non-linear relationship between ESG scores and Tobin’s Q.

Suggested Citation

  • Sophia Veronica Barbieri & Laura Pellegrini, 2022. "How Much Does Matter ESG Ratings in Big Pharma Firms Performances?," Palgrave Studies in Impact Finance, in: Carlo Bellavite Pellegrini & Laura Pellegrini & Massimo Catizone (ed.), Climate Change Adaptation, Governance and New Issues of Value, chapter 0, pages 185-225, Palgrave Macmillan.
    • Handle: RePEc:pal:psifcp:978-3-030-90115-8_9
    DOI: 10.1007/978-3-030-90115-8_9
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pal:psifcp:978-3-030-90115-8_9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.palgrave.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.